The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
Long Covid advocates face challenges, potential discrimination with billboard campaignsLong Covid advocates face challenges, potential discrimination with billboard campaignsSimon Spichak
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • A microscopic image of lymphatic vessels in the meninges,
    March 25, 2025

    Research updates, March 25

  • diabetic kit and medicines over a purple surface
    March 18, 2025

    Research updates, March 18

  • a doctor using a device
    March 11, 2025

    Research updates, March 11

  • Microscope image of a human lung cell, dyed in pink and purple
    March 4, 2025

    Research updates, March 4

  • A group of refugees from Mozambique, wearing colorful clothing and face masks.
    February 25, 2025

    False hope: In Sub-Saharan Africa, wars damage Long COVID research and surveillance

  • pexels-photo-5863389.jpeg
    February 25, 2025

    Research updates, February 25

Previous Page
1 … 19 20 21 22 23 … 38
Next Page

Covid-19

  • A map of the United States color-coded in shades of maroon, orange, and gray displaying SARS-CoV-2 Wastewater Viral Activity level as of September 21, 2024, where deeper tones correlate to higher viral activity and gray indicates “Insufficient,” or “No Data.” Text above the map reads “Very High” or “High” levels in 34 states. Data is unavailable for Guam, North Dakota, and the U.S. Virgin Islands. At the bottom, text reads People’s CDC. Source: CDC.
    October 1, 2024

    National COVID-19 trends, October 1

  • September 24, 2024

    National COVID-19 trends, September 24

  • September 17, 2024

    National COVID-19 trends, September 17

  • Collage showing a crate of rapid at-home COVID-19 tests, a map of mask bloc locations, a box of 3M N95 respirators, and a flyer from a mask bloc in Nassau County and Queens, New York introducing how mask blocs distribute free high-quality masks in their communities
    September 10, 2024

    A brief, oral history of mask blocs: Part 1

  • Line chart titled, "Percentage of Emergency Department Visits with Diagnosed COVID-19 in United States, by Age Group." The chart shows this ratio from September 2023 to September 2024. Children ages 0 to 11, shown with a yellow dotted line, had the highest percentage in late summer 2024, higher than even ages 75+ (shown in purple).
    September 10, 2024

    National COVID-19 trends, September 10

  • September 3, 2024

    “Perfect storm” of criminalization: Analyzing mask bans

Previous Page
1 … 19 20 21 22 23 … 31
Next Page

Health

Commentary

  • A young person lies in bed in a dark room, with an eye mask over their face and earplugs in.
    January 13, 2026

    Severe people may hold answers to Long COVID. They must be included in research.

  • ID: Graphic showing an old desktop computer with a pixelated red umbrella, an international symbol for sex worker rights, on the screen. The image's background is black with white pixels.
    January 6, 2026

    Long COVID advocacy is incomplete without sex workers

  • December 19, 2025

    Telehealth is vital for people with Long COVID. Don’t let it disappear.

  • December 9, 2025

    Doctors who refuse to engage with administrative work are abandoning their poorest and sickest patients

Previous Page
1 … 6 7 8 9 10 … 27
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...